Rezultaty - Kathi Seidl-Rathkopf
- Rezultaty 1 - 2 Rezultaty od 2
-
1
Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical Trials od Jeremy O’Connor, Kristen L. Fessele, Jean Steiner, Kathi Seidl-Rathkopf, Kenneth R. Carson, Nathan C. Nussbaum, Emily S. Yin, Kerin B. Adelson, Carolyn J. Presley, Anne C. Chiang, Joseph S. Ross, Amy P. Abernethy, Cary P. Gross
Wydane 2018Artigo -
2
Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non–Small Cell Lung Cancer Using a Clinicogenomic Database od Gaurav Singal, Peter G. Miller, Vineeta Agarwala, Gerald Li, Gaurav Kaushik, Daniel Backenroth, Anala Gossai, Garrett M. Frampton, Aracelis Z. Torres, Erik Lehnert, David Bourque, Claire O’Connell, Bryan Bowser, Thomas Caron, Ezra Baydur, Kathi Seidl-Rathkopf, Ivan Ivanov, Garrett Alpha-Cobb, Ameet Guria, Jie He, Shannon Frank, Allen C. Nunnally, Mark Bailey, Ann Jaskiw, Dana Feuchtbaum, Nathan C. Nussbaum, Amy P. Abernethy, Vincent A. Miller
Wydane 2019Artigo